PF-Atlas › Clinical Trials › NCT06660992

A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis

HSK31858, tablet · Phase 3

Registry ID
NCT06660992
Phase
Phase 3
Status
Recruiting
Drug / intervention
HSK31858, tablet
Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Start
2024-09-30
Enrollment
669
Locations
2

About this trial

This is a phase III, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of HSK31858 in non-cystic fibrosis bronchiectasis (NCFBE) participants.

View NCT06660992 on ClinicalTrials.gov →

Explore related

All HSK31858, tablet trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT06660992 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.